Tag: bureaucracy
Reducing bureaucracy in clinical trials: now is the time!
![Reducing bureaucracy in clinical trials now is the time 1](/assets/Uploads/Reducing-bureaucracy-in-clinical-trials-now-is-the-time-1__ScaleMaxWidthWzY0MF0.png)
Medical societies and patient advocates across disciplines have joined forces with EHA to call for urgent action to make clinical trials less bureaucratic and more patient-centered, efficient and cheaper.
Addressing the bureaucracy challenge
![HemAffairs afbeelding 2](/assets/Uploads/HemAffairs-afbeelding-2__ScaleMaxWidthWzY0MF0.png)
EHA has recently brought key stakeholders around the table to discuss bureaucratic obstacles in clinical research. Regulators, patient organizations, the European Commission and industry representatives were invited for a day-long discussion at EHA offices, building on an informal dialogue with the European Medicines Agency (EMA) that had been initiated by a group of prominent clinical researchers.